FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038650018> ?p ?o ?g. }

• W2038650018 endingPage "111" @default.
• W2038650018 startingPage "105" @default.
• W2038650018 abstract "Voltage-gated sodium channels (Na(V) channels) play a pivotal role in neuronal excitability; they are specifically targeted by μ-conotoxins from the venom of marine cone snails. These peptide toxins bind to the outer vestibule of the channel pore thereby blocking ion conduction through Na(V) channels. μ-Conotoxin SIIIA from Conus striatus was shown to be a potent inhibitor of neuronal sodium channels and to display analgesic effects in mice, albeit the molecular targets are not unambiguously known. We therefore studied recombinant Na(V) channels expressed in mammalian cells using the whole-cell patch-clamp method. Synthetic μSIIIA slowly and partially blocked rat Na(V)1.4 channels with an apparent IC(50) of 0.56 ± 0.29 μM; the block was not complete, leaving at high concentration a residual current component of about 10% with a correspondingly reduced single-channel conductance. At 10 μM, μSIIIA potently blocked rat Na(V)1.2, rat and human Na(V)1.4, and mouse Na(V)1.6 channels; human Na(V)1.7 channels were only inhibited by 58.1 ± 4.9%, whereas human Na(V)1.5 as well as rat and human Na(V)1.8 were insensitive. Employing domain chimeras between rNa(V)1.4 and hNa(V)1.5, we located the determinants for μSIIIA specificity in the first half of the channel protein with a major contribution of domain-2 and a minor contribution of domain-1. The latter was largely accounted for by the alteration in the TTX-binding site (Tyr401 in rNa(V)1.4, Cys for Na(V)1.5, and Ser for Na(V)1.8). Introduction of domain-2 pore loops of all tested channel isoforms into rNa(V)1.4 conferred the μSIIIA phenotype of the respective donor channels highlighting the importance of the domain-2 pore loop as the major determinant for μSIIIA's subtype specificity. Single-site substitutions identified residue Ala728 in rNa(V)1.4 as crucial for its high sensitivity toward μSIIIA. Likewise, Asn889 at the homologous position in hNa(V)1.7 is responsible for the channel's reduced μSIIIA sensitivity. These results will pave the way for the rational design of selective Na(V)-channel antagonists for research and medical applications." @default.
• W2038650018 created "2016-06-24" @default.
• W2038650018 creator A5011350139 @default.
• W2038650018 creator A5013013547 @default.
• W2038650018 creator A5038203459 @default.
• W2038650018 creator A5056683037 @default.
• W2038650018 creator A5060630266 @default.
• W2038650018 creator A5078435642 @default.
• W2038650018 creator A5080625356 @default.
• W2038650018 date "2011-07-01" @default.
• W2038650018 modified "2023-10-01" @default.
• W2038650018 title "Molecular determinants for the subtype specificity of μ-conotoxin SIIIA targeting neuronal voltage-gated sodium channels" @default.
• W2038650018 cites W1533368723 @default.
• W2038650018 cites W163561699 @default.
• W2038650018 cites W1835398160 @default.
• W2038650018 cites W1943370252 @default.
• W2038650018 cites W1973547473 @default.
• W2038650018 cites W1978082048 @default.
• W2038650018 cites W1978945640 @default.
• W2038650018 cites W1983596288 @default.
• W2038650018 cites W1985689777 @default.
• W2038650018 cites W1994682680 @default.
• W2038650018 cites W1994810384 @default.
• W2038650018 cites W1997594148 @default.
• W2038650018 cites W2000702493 @default.
• W2038650018 cites W2003275821 @default.
• W2038650018 cites W2019037429 @default.
• W2038650018 cites W2027085605 @default.
• W2038650018 cites W2028709900 @default.
• W2038650018 cites W2044742798 @default.
• W2038650018 cites W2048368158 @default.
• W2038650018 cites W2054989950 @default.
• W2038650018 cites W2056261720 @default.
• W2038650018 cites W2065928015 @default.
• W2038650018 cites W2070676751 @default.
• W2038650018 cites W2071151959 @default.
• W2038650018 cites W2078840491 @default.
• W2038650018 cites W2082491048 @default.
• W2038650018 cites W2082808211 @default.
• W2038650018 cites W2091164194 @default.
• W2038650018 cites W2091746433 @default.
• W2038650018 cites W2093012301 @default.
• W2038650018 cites W2093297294 @default.
• W2038650018 cites W2098450505 @default.
• W2038650018 cites W2100409593 @default.
• W2038650018 cites W2103410499 @default.
• W2038650018 cites W2108114952 @default.
• W2038650018 cites W2117289838 @default.
• W2038650018 cites W2130050127 @default.
• W2038650018 cites W2134353614 @default.
• W2038650018 cites W2134571618 @default.
• W2038650018 cites W2142037285 @default.
• W2038650018 cites W2142567184 @default.
• W2038650018 cites W2150869428 @default.
• W2038650018 cites W2316282919 @default.
• W2038650018 cites W2323694911 @default.
• W2038650018 cites W4234783407 @default.
• W2038650018 doi "https://doi.org/10.1016/j.neuropharm.2011.03.008" @default.
• W2038650018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21419143" @default.
• W2038650018 hasPublicationYear "2011" @default.
• W2038650018 type Work @default.
• W2038650018 sameAs 2038650018 @default.
• W2038650018 citedByCount "28" @default.
• W2038650018 countsByYear W20386500182012 @default.
• W2038650018 countsByYear W20386500182013 @default.
• W2038650018 countsByYear W20386500182014 @default.
• W2038650018 countsByYear W20386500182015 @default.
• W2038650018 countsByYear W20386500182016 @default.
• W2038650018 countsByYear W20386500182017 @default.
• W2038650018 countsByYear W20386500182018 @default.
• W2038650018 countsByYear W20386500182019 @default.
• W2038650018 countsByYear W20386500182020 @default.
• W2038650018 countsByYear W20386500182021 @default.
• W2038650018 countsByYear W20386500182022 @default.
• W2038650018 countsByYear W20386500182023 @default.
• W2038650018 crossrefType "journal-article" @default.
• W2038650018 hasAuthorship W2038650018A5011350139 @default.
• W2038650018 hasAuthorship W2038650018A5013013547 @default.
• W2038650018 hasAuthorship W2038650018A5038203459 @default.
• W2038650018 hasAuthorship W2038650018A5056683037 @default.
• W2038650018 hasAuthorship W2038650018A5060630266 @default.
• W2038650018 hasAuthorship W2038650018A5078435642 @default.
• W2038650018 hasAuthorship W2038650018A5080625356 @default.
• W2038650018 hasConcept C100837961 @default.
• W2038650018 hasConcept C12554922 @default.
• W2038650018 hasConcept C147944092 @default.
• W2038650018 hasConcept C153911025 @default.
• W2038650018 hasConcept C170493617 @default.
• W2038650018 hasConcept C175234850 @default.
• W2038650018 hasConcept C178790620 @default.
• W2038650018 hasConcept C181911157 @default.
• W2038650018 hasConcept C185592680 @default.
• W2038650018 hasConcept C2779448229 @default.
• W2038650018 hasConcept C37088560 @default.
• W2038650018 hasConcept C50254741 @default.
• W2038650018 hasConcept C50952357 @default.
• W2038650018 hasConcept C537181965 @default.
• W2038650018 hasConcept C55493867 @default.

• next